Pascal Cohen

16.4k total citations · 1 hit paper
134 papers, 7.1k citations indexed

About

Pascal Cohen is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Physiology. According to data from OpenAlex, Pascal Cohen has authored 134 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Pulmonary and Respiratory Medicine, 58 papers in Rheumatology and 36 papers in Physiology. Recurrent topics in Pascal Cohen's work include Vasculitis and related conditions (90 papers), Sarcoidosis and Beryllium Toxicity Research (33 papers) and Eosinophilic Disorders and Syndromes (16 papers). Pascal Cohen is often cited by papers focused on Vasculitis and related conditions (90 papers), Sarcoidosis and Beryllium Toxicity Research (33 papers) and Eosinophilic Disorders and Syndromes (16 papers). Pascal Cohen collaborates with scholars based in France, Canada and Switzerland. Pascal Cohen's co-authors include Loı̈c Guillevin, Christian Pagnoux, Alfred Mahr, Luc Mouthon, B Jarrousse, M. Gayraud, Philippe Casassus, Xavier Puéchal, François Lhote and Véronique Le Guern and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Pascal Cohen

128 papers receiving 6.9k citations

Hit Papers

Prognostic Factors in Polyarteritis Nodosa and Churg-Stra... 1996 2026 2006 2016 1996 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Cohen France 36 5.3k 3.5k 2.1k 930 838 134 7.1k
Daniël Blockmans Belgium 41 4.7k 0.9× 4.1k 1.2× 1.3k 0.6× 1.3k 1.4× 948 1.1× 190 7.7k
Xavier Puéchal France 46 3.0k 0.6× 3.3k 0.9× 1.7k 0.8× 897 1.0× 1.1k 1.3× 213 7.1k
Steven R. Ytterberg United States 40 3.0k 0.6× 3.4k 1.0× 922 0.4× 1.2k 1.2× 602 0.7× 131 6.7k
Niels Rasmussen Denmark 38 7.2k 1.4× 2.8k 0.8× 2.9k 1.4× 2.2k 2.4× 595 0.7× 104 8.6k
M Ingelmo Spain 54 1.3k 0.2× 6.4k 1.8× 1.3k 0.6× 449 0.5× 996 1.2× 158 9.2k
Bernhard Hellmich Germany 38 4.7k 0.9× 2.9k 0.8× 1.5k 0.8× 1.1k 1.2× 608 0.7× 160 6.2k
O Blétry France 37 1.4k 0.3× 1.8k 0.5× 723 0.4× 327 0.4× 857 1.0× 215 4.1k
Pierre‐Yves Hatron France 42 2.0k 0.4× 1.7k 0.5× 1.2k 0.6× 302 0.3× 1.0k 1.2× 142 5.7k
Christian Dejaco Austria 40 2.6k 0.5× 2.8k 0.8× 654 0.3× 1.0k 1.1× 533 0.6× 209 5.4k
M. Hamidou France 38 1.3k 0.3× 1.3k 0.4× 706 0.3× 806 0.9× 484 0.6× 229 4.4k

Countries citing papers authored by Pascal Cohen

Since Specialization
Citations

This map shows the geographic impact of Pascal Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Cohen more than expected).

Fields of papers citing papers by Pascal Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Cohen. The network helps show where Pascal Cohen may publish in the future.

Co-authorship network of co-authors of Pascal Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Cohen. A scholar is included among the top collaborators of Pascal Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Cohen. Pascal Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chouchana, Laurent, Marion Casadevall, Pascal Cohen, et al.. (2024). Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.. Seminars in Arthritis and Rheumatism. 67. 152469–152469.
2.
Nguyen, Yann, Jérôme Hadjadj, Pascal Cohen, et al.. (2023). Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study. Journal of Autoimmunity. 142. 103130–103130. 3 indexed citations
3.
Samson, Maxime, H. Devilliers, Sara Thietart, et al.. (2023). Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis. RMD Open. 9(1). e002953–e002953. 6 indexed citations
4.
Hoang-Thi, Trieu-Nghi, Raphaël Porcher, Bertrand Dunogué, et al.. (2023). Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis. Lara D. Veeken. 63(1). 103–110. 12 indexed citations
5.
Chaigne, Benjamin, Bertrand Dunogué, Alexis Régent, et al.. (2022). Autoantibodies versus Skin Fibrosis Extent in Systemic Sclerosis: A Case-Control Study of Inverted Phenotypes. Diagnostics. 12(5). 1067–1067. 12 indexed citations
6.
Uzunhan, Y., Romain Paule, Jérémie Dion, et al.. (2021). Presentation, Diagnosis, and Management of Subglottic and Tracheal Stenosis During Systemic Inflammatory Diseases. CHEST Journal. 161(1). 257–265. 14 indexed citations
7.
London, Jonathan, Sébastien Lofek, Jérémie Dion, et al.. (2020). Skewed peripheral B- and T-cell compartments in patients with ANCA-associated vasculitis. Lara D. Veeken. 60(5). 2157–2168. 8 indexed citations
10.
Samson, M., Xavier Puéchal, Luc Mouthon, et al.. (2017). Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial.. PubMed. 35 Suppl 103(1). 176–184. 18 indexed citations
11.
Benarous, Lucas, Benjamin Terrier, Hervé Laborde‐Castérot, et al.. (2017). Employment, work disability and quality of life in patients with ANCA-associated vasculitides. The EXPOVAS study.. PubMed. 35 Suppl 103(1). 40–46. 23 indexed citations
12.
Girard, Charlotte, Pierre Charles, Benjamin Terrier, et al.. (2015). Tracheobronchial Stenoses in Granulomatosis With Polyangiitis (Wegener's). Medicine. 94(32). e1088–e1088. 50 indexed citations
13.
Roubaud‐Baudron, Claire, Christian Pagnoux, N. Méaux-Ruault, et al.. (2011). Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis. The Journal of Rheumatology. 39(1). 125–130. 57 indexed citations
14.
Gottenberg, Jacques‐Eric, Alfred Mahr, Christian Pagnoux, et al.. (2007). Long-term outcome of 37 patients with Wegener's granulomatosis with renal involvement. La Presse Médicale. 36(5). 771–778. 18 indexed citations
15.
Séror, Raphaèle, Alfred Mahr, J. Ramanoelina, et al.. (2006). Central Nervous System Involvement in Wegener Granulomatosis. Medicine. 85(1). 53–65. 154 indexed citations
16.
Cacoub, P., Christophe Renou, Éric Rosenthal, et al.. (2000). Extrahepatic Manifestations Associated with Hepatitis C Virus Infection: A Prospective Multicenter Study of 321 Patients. Medicine. 79(1). 47–56. 418 indexed citations
17.
Cohen, Pascal. (2000). Le syndrome de Churg et Strauss. Sang thrombose vaisseaux. 12(8). 3 indexed citations
18.
Généreau, T, Olivier Lortholary, Loı̈c Guillevin, et al.. (1999). Temporal 67gallium uptake is increased in temporal arteritis. Lara D. Veeken. 38(8). 709–713. 26 indexed citations
19.
Leruez‐Ville, Marianne, et al.. (1998). Large-scale analysis of hepatitis C virus serological typing assay: Effectiveness and limits. Journal of Medical Virology. 55(1). 18–23. 18 indexed citations
20.
Cohen, Pascal, et al.. (1997). Linear basal cell carcinomas: report of multiple sequential tumors localized to a radiotherapy port and review of the literature.. PubMed. 93(7). 57–9. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026